This site is intended for healthcare professionals only
LoginRegister

Medicine Dialogues

Rare Case Links Apixaban to Severe Periorbital Dermatitis: Highlights Need for Vigilance in Dermatological Reactions

Rare Case Links Apixaban to Severe Periorbital Dermatitis: Highlights Need for Vigilance in...

USA: In a rare clinical presentation, researchers have documented a case of periorbital dermatitis linked to the use of apixaban, a commonly...
View All

Latest News and Guidelines

Bariatric Surgery Reduces Risk of CRS and Sinus Surgeries by Up to 48% in Obese Patients: Study

Bariatric Surgery Reduces Risk of CRS and Sinus Surgeries by Up to 48% in Obese Patients: Study

GSK to buy efimosfermin to treat, prevent progression of steatotic liver disease

GSK to acquire liver disease drug Efimosfermin for up to USD 2 billion

Alembic Pharma gets USFDA nod for cardio drug Rivaroxaban

USFDA clears Alembic Pharma cardio drug Rivaroxaban, launch expected in next year

First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

Merck bags USFDA nod for Welireg for 12 years and older with pheochromocytoma or paraganglioma

Merck scores USFDA OK for Welireg for 12 years and older with pheochromocytoma or paraganglioma

AbbVie Emrelis gets USFDA accelerated approval for a type of lung cancer

AbbVie Emrelis gets USFDA accelerated approval for a type of lung cancer

View All
X